A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
NCT05513742
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Colorectal Cancer
Colon Cancer
Rectal Cancer
Interventions
DRUG:
CTX-009
Sponsor
Compass Therapeutics